CoChat

Self-Monitoring of Blood Glucose in Diabetes: From Evidence to Clinical Reality in Central and Eastern Europe—Recommendations from the International Central-Eastern European Expert Group

Open access
Czupryniak, Leszek, Barkai, László, Bolgarska, Svetlana, Bronisz, Agata, Broz, Jan, Cypryk, Katarzyna, Honka, Marek, Janez, Andrej, Krnic, Mladen, Lalic, Nebojsa, Martinka, Emil, Rahelic, Dario, Roman, Gabriela, Tankova, Tsvetalina, Várkonyi, Tamás, Wolnik, Bogumił, Zherdova, Nadia · 2014 · Diabetes Technology & Therapeutics
Cited by 93

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Self-monitoring of blood glucose (SMBG) is universally considered to be an integral part of type 1 diabetes management and crucial for optimizing the safety and efficacy of complex insulin regimens. This extends to type 2 diabetes patients on intensive insulin therapy, and there is also a growing body of evidence suggesting that structured SMBG is beneficial for all type 2 diabetes patients, regardless of therapy. However, access to SMBG can be limited in many countries in Central and Eastern Europe. A consensus group of diabetes experts from 10 countries in this region (with overlapping historical, political, and social environments)--Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Serbia, Slovakia, Slovenia, and Ukraine--was formed to discuss the role of SMBG across the spectrum of patients with diabetes. The group considered SMBG to be an essential tool that should be accessible to all patients with diabetes, including those with non-insulin-treated type 2 diabetes. The current article summarizes the evidence put forward by the consensus group and provides their recommendations for the appropriate use of SMBG as part of individualized patient management. The ultimate goal of these evidence-based recommendations is to help patients and providers in Central and Eastern Europe to make optimal use of SMBG in order to maximize the efficacy and safety of glucose-lowering therapies, to prevent complications, and to empower the patient to play a more active role in the management of their diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/dia.2013.0302

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 93

Metadata

Authors
Czupryniak, L., Barkai, L., Bolgarska, S., Bronisz, A., Broz, J., Cypryk, K., Honka, M., Janez, A., Krnic, M., Lalic, N., Martinka, E., Rahelic, D., Roman, G., Tankova, T., Várkonyi, T., Wolnik, B., & Zherdova, N.
Venue
Diabetes Technology & Therapeutics
Published
2014-07
Volume
16
Issue
7
Pages
460-475
ISSN
  • 1520-9156 (ISSN-L)
  • 1557-8593
OpenAlex
W2053834796
Cited by
93
References
31
FWCI
2.63
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Self-Monitoring of Blood Glucose in Diabetes: From Evidence to Clinical Reality in Central and Eastern Europe—Recommendations from the International Central-Eastern European Expert Group. https://app.cochat.ai/papers/10.1089/dia.2013.0302
The paper
Czupryniak, L., Barkai, L., Bolgarska, S., Bronisz, A., Broz, J., Cypryk, K., Honka, M., Janez, A., Krnic, M., Lalic, N., Martinka, E., Rahelic, D., Roman, G., Tankova, T., Várkonyi, T., Wolnik, B., & Zherdova, N. (2014). Self-Monitoring of Blood Glucose in Diabetes: From Evidence to Clinical Reality in Central and Eastern Europe—Recommendations from the International Central-Eastern European Expert Group. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2013.0302

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.